These include those focused libraries of small-molecule compounds with their specific applications (Antibiotics Library, CNS-Penetrant Compound Library, DNA Damage & Repair Compound Library, Neural Regeneration Compound Library, PPI Inhibitors Library, etc.).
Cat No. | product name | ||
---|---|---|---|
L5500 | Toxic Compound Library | A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | 277 compounds |
L1380 | Transcription Factor-Targeted Compound Library | Quantity: well-chosen 449 compounds with unique structures targeting transcription factor; | 449 compounds |
L5510 | Drug-induced Liver Injury (DILI) Compound Library | A unique collection of 939 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | 939 compounds |
L7700 | Neural Regeneration Compound Library | A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | 529 compounds |
L9410 | Covalent Inhibitor Library | A unique collection of 943 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. | 943 compounds |
L2540 | Gut Microbial Metabolite Library | 352 compounds | |
L3100 | Hematopoietic Toxicity Compound Library | A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | 104 compounds |
L1720 | Nucleotide Compound Library | A unique collection of 255 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | 255 compounds |
L9820 | Beta-Lactam Compound Library | 90 compounds | |
L8000 | Stem Cell Differentiation Compound Library | A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | 1213 compounds |
L2530 | Mouse Metabolite Compound Library | 203 compounds | |
L7900 | Osteogenesis Compound Library | A unique collection of 100 osteogenesis related compounds for high throughput and high content screening; | 100 compounds |
L8300 | Chromatin Modification Compound Library | A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | 256 compounds |
L2400 | Endocrinology-Hormone Compound Library | A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | 813 compounds |
L9600 | Peptide Compound Library | 533 compounds | |
L2520 | Glycometabolism Compound Library | 638 compounds | |
L5100 | Fluorochemical Library | A unique collection of 586 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | 586 compounds |
L4900 | Cardiotoxicity Compound Library | A unique collection of 132 cardiotoxicity inducing compounds for toxicological study; | 132 compounds |
L3500 | Histone Modification Compound Library | A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | 362 compounds |
L7000 | Bioactive Lipid Compound Library | A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsaturated fatty acids, Leukotrienes, lipoxins, LPA & phosphatidic acids, Octadecanoids, PAFs, Prostaglandins & thromboxanes, Retinoids, vitamin D metabolites, Sphingolipids, etc.; | 385 compounds |
L7500 | Coagulation and Anticoagulation Compound Library | A unique collection of 153 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | 154 compounds |
L5900 | CNS-Penetrant Compound Library | A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | 516 compounds |
L5800 | Drug Metabolite/Impurity Library | A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | 200 compounds |
L3980 | DNA Damage and Repair Compound Library Plus | Quantity: well-chosen 667 compounds with unique structures targeting DNA damage & repair; | 667 compounds |
L4400 | Antibiotics Library | A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | 708 compounds |
L2900 | Oxidation-Reduction Compound Library | 453 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | 453 compounds |
L2510 | Lipid Metabolism Compound Library | 376 compounds | |
L2500 | Human Endogenous Metabolite Library | A unique collection of 910 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | 910 compounds |
L9500 | Target-Focused Phenotypic Screening Library | A unique collection of 2623 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | 2623 compounds |
L9300 | Macrocyclic Compound Library | 155 macrocyclic compounds of known activity for high-throughput, high-content screening; | 155 compounds |
L9400 | PPI Inhibitor Library | A unique collection of 260 PPI-related compounds for drug screening; | 260 compounds |
L8200 | Anti-Aging Compound Library | A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | 3324 compounds |
L2550 | Glutamine Metabolism Compound Library | 455 compounds |